
Here's Why Keysight ( KEYS ) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Predicted Price is the pryogiTM prediction of where the price is going in next 3-4 quarters. There may be a revision of the predicted price every 3 months from the date of publication of the first predicted price of the stock. Price on Report Date is the price of the stock on the day prediction was published by pryogiTM. Current price shows the current price of the stock.
Margin of error shows range the price will end up in dollars either above or below the predicted price. Margin of error percentage shows the price will end up in percentage either above or below the predicted price.
Expected Returns from report date shows the returns (positive or negative) from published prediction date if you bought the stock on report date. Expected Returns from today shows the returns from today if you buy the stock today. A positive expected returns indicates a profit you will make, a negative expected return indicates a loss you will make if you buy the stock. There are different strategies to apply in the stock market for profit and loss, pryogiTM will publish such strategies in the future to help you.
PryogiTM meter shows you predicted price, price on the date this prediction was published(report date) and price of the stock today on a price scale. This indicates if the stock price is moving towards or away from the predicted price
PryogiTM performance chart shows actual movement of stock price from prediction published date(report date) and if the price is moving towards or away from predicted price
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
A posts fiscal Q3 earnings and revenue beats, with double-digit sales growth and upbeat guidance lifting shares.
Agilent Technologies ( NYSE:A ) , a global leader in laboratory instruments and scientific solutions for life sciences and diagnostics, released its Q3 fiscal 2025 results on Aug. 27, 2025. The company delivered revenue of $1.74 billion, coming in over its own projected revenue guidance and ...
Agilent Technologies ( NYSE:A ) reported Q3 FY2025 revenue of $1.74 billion, up 6.1% year-over-year on a core basis, with non-GAAP EPS of $1.37, both exceeding guidance. The company raised its full-year revenue outlook to $6.91 billion-$6.93 billion ( core growth 4.5% at midpoint ) , despite ...
Agilent (A) delivered earnings and revenue surprises of +0.74% and +4.60%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
Wall Street trades cautiously as investors await Nvidia's earnings, with major indices hovering near record highs. Nvidia stock edges up 0.1%; traders eye Blackwell chip growth, China updates and margins as key drivers.
Austin, TX, USA, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "Chemical Reagents Market Size, Trends and Insights By Product Type ( Solvents, Acids & Bases, Oxidizing & Reducing Agents, Buffers & Standards, Catalysts ) , By Application ( ...
Besides Wall Street's top-and-bottom-line estimates for Agilent (A), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025.
Boston, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, the "Genome Editing: Technologies and Global Markets" is projected to grow from $10.8 billion in 2025 to $23.7 billion by the end of 2030, at a compound annual growth rate ( CAGR ) of 16.9% during the ...
Allurion Technologies, Inc. (ALUR) delivered earnings and revenue surprises of +12.31% and -43.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GEHC vs. A: Which Stock Is the Better Value Option?
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 0.00% and +1.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Sanara MedTech (SMTI) delivered earnings and revenue surprises of +30.30% and +1.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Burlingame, CA, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- The global Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn in 2032, exhibiting a compound annual growth rate ( CAGR ) of 8.7% from 2025 to 2032.
TerrAscend Corp. (TSNDF) delivered earnings and revenue surprises of -50.00% and +0.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
This aviation pioneer is poised to potentially usher in transportation's next major milestone.
Austin, TX, USA, July 25, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "CRISPR Gene Editing Market Size, Trends and Insights By Product ( Kits and Reagents, Services ) , By Gene Editing Modality ( Ex-Vivo Editing, In-Vivo Editing ) , By Technology ...
In the current session, Agilent Technologies Inc. A is trading at $115.19, after a 1.01% drop. Over the past month, the stock fell by 1.07%, and in the past year, by 14.32%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ...
Agilent Technologies's A short percent of float has fallen 18.29% since its last report. The company recently reported that it has 3.35 million shares sold short, which is 1.34% of all regular shares that are available for trading.
Lewes, Delaware, July 14, 2025 ( GLOBE NEWSWIRE ) -- The Global In Situ Hybridization Market Size is projected to grow at a CAGR of 8.97% from 2024 to 2031, according to a new report published by Verified Market Research®.
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Investors need to pay close attention to Agilent Technologies stock based on the movements in the options market lately.
The Benzinga Stock Whisper Index highlights five stocks each week seeing more interest from readers than normal. Tariffs could impact one of the company's on the list in their next financial results. Geopolitical tensions, Fed uncertainty, and fast-moving headlines are driving July volatility.
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Delray Beach, FL, June 27, 2025 ( GLOBE NEWSWIRE ) -- The global laboratory information management system market, valued at US$2.54 billion in 2024, stood at US$2.88 billion in 2025 and is projected to advance at a resilient CAGR of 12.5% from 2025 to 2030, culminating in a forecasted valuation ...
CAMBRIDGE, Mass., June 25, 2025 ( GLOBE NEWSWIRE ) -- Arbor Biotechnologies™, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Mikael Dolsten, M.D., Ph.D., to its Board of Directors.
Agilent Technologies's A short percent of float has fallen 5.17% since its last report. The company recently reported that it has 4.14 million shares sold short, which is 1.65% of all regular shares that are available for trading.
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
NEW YORK and PARIS, June 18, 2025 ( GLOBE NEWSWIRE ) -- Rarecells, Inc., a leader in liquid biopsy technology, is pleased to announce the appointment of Dr. Rita Shaknovich to its Scientific Advisory Board. Dr. Shaknovich brings over 20 years of leadership experience across private industry and ...
Delray Beach, FL, June 11, 2025 ( GLOBE NEWSWIRE ) -- The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance at a resilient CAGR of 9.4% from 2024 to 2029, culminating in a forecasted valuation of US$66.8 billion by the end of ...
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
A's second-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.
U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 100 points on Thursday. Shares of Veeva Systems Inc. VEEV rose sharply during Thursday's session following strong quarterly results. The company reported adjusted earnings per share of $1.97, beating the analyst consensus ...
Q2 adjusted EPS rose to $1.31 vs. $1.26 consensus, up from $1.22 a year ago. Agilent ups FY25 revenue forecast to $6.73 billion-$6.81 billion, from prior $6.68 billion-$6.76 billion. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and stock ideas-now 60% off for ...
Agilent (A) delivered earnings and revenue surprises of 3.97% and 2.64%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Judy Brown, Board Member at Agilent Technologies A, reported an insider buy on May 23, according to a new SEC filing. What Happened: Brown made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission.
Pascal Soriot, Director at Agilent Technologies A, reported an insider buy on May 23, according to a new SEC filing. What Happened: Soriot made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.
US & Canada, May 19, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the global digital PCR and real-time PCR market is witnessing substantial growth with the surging incidence of genetic and infectious diseases and rising investments in gene ...
Sanara MedTech (SMTI) delivered earnings and revenue surprises of -32.26% and 5.32%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Agilent Technologies's A short percent of float has risen 17.01% since its last report. The company recently reported that it has 4.32 million shares sold short, which is 1.72% of all regular shares that are available for trading.
Zimmer (ZBH) delivered earnings and revenue surprises of 2.84% and 0.88%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
SYK's first-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
DexCom Q1 results are likely to reflect strong growth on the back of coverage by two large PBMs and Stelo traction, driving momentum and market expansion in 2025.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.
Investors need to pay close attention to A stock based on the movements in the options market lately.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.